Furthermore, they evaluated cell invasion under conditions of loss or gain of function of these α-catenins, supporting the hypothesis that CTNNA2 and CTNNA3 are tumor suppressor genes and their genetic inactivation endows HNSCC cells with migration and invasion advantages, thus contributing to LSCC progression [55]. The gene discussed is CTNNA3; the disease is neoplasm.